Literature DB >> 6361977

Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis.

C U Tuazon, H Miller.   

Abstract

10 patients with serious infections caused by Staphylococcus epidermidis (8 cases of endocarditis in non-prosthetic valves, 1 was complicated by osteomyelitis, 1 case of osteomyelitis, and 1 case of septicemia) are described. Clinical and microbiologic features were evaluated including antibiotic sensitivity and synergy studies, phage typing and biotyping. Endocarditis tended to affect the elderly population and the clinical manifestations were quite similar to those caused by Streptococcus viridans. Both patients with osteomyelitis had involvement of the cervical spine with excellent response to antibiotic therapy. The only patient with septicemia acquired via hyperalimentation had delayed clearance of the bacteremia but ultimately responded to intravenous antibiotics. Rifampicin was the most effective of all antibiotics tested. All isolates were sensitive to penicillinase-resistant penicillins and cephalosporins and over half were sensitive to penicillin. Full synergistic activity was demonstrated with cephalothin and nafcillin in combination with rifampicin, and rifampicin-vancomycin was partially synergistic against the majority of the strains. Five of 8 available isolates were non-phage typeable and no definite pattern was established for various types of infections. Four of the 8 isolates were classified as biotype SIIa, 2 biotype SIIc and 2 biotype SVh.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361977     DOI: 10.3109/inf.1983.15.issue-4.05

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  12 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

2.  In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.

Authors:  M Arditi; R Yogev
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

3.  Plasmid analysis as an epidemiological tool in neurosurgical infections with coagulase-negative staphylococci.

Authors:  A Ortqvist; U Ransjö; B Wretlind
Journal:  Epidemiol Infect       Date:  1987-06       Impact factor: 2.451

4.  Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.

Authors:  W M Milewski; S Boyle-Vavra; B Moreira; C C Ebert; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 5.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study.

Authors:  J Etienne; S J Eykyn
Journal:  Br Heart J       Date:  1990-12

Review 7.  Anti-infective treatment in intensive care: the role of glycopeptides.

Authors:  R N Grüneberg; A P Wilson
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

Review 8.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri.

Authors:  Kimberly J Center; Annette C Reboli; Robin Hubler; Gail L Rodgers; Sarah S Long
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Recovery of resistant enterococci during vancomycin prophylaxis.

Authors:  A H Kaplan; P H Gilligan; R R Facklam
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.